Recursion Pharmaceuticals Inc Working Capital to Net Assets Ratio
Recursion Pharmaceuticals Inc working capital to net assets ratio. Recursion Pharmaceuticals Inc (RXRX) has a Working Capital to Net Assets ratio of 52.8% as of June 2026. Working capital of $483.58 Million (current assets of $603.46 Million minus current liabilities of $119.89 Million) is measured against net assets of $915.00 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Recursion Pharmaceuticals Inc (2019–2025)
Working capital to net assets ratio of Recursion Pharmaceuticals Inc from 2019 to 2025. This chart shows how Recursion Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the ratio stands at 52.8%, reflecting working capital of $483.58 Million against net assets of $915.00 Million USD. See RXRX defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Recursion Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2019–2025)
Recursion Pharmaceuticals Inc working capital to net assets ratio by year from 2019 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Recursion Pharmaceuticals Inc from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Recursion Pharmaceuticals Inc's balance sheet.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 58.8% | $665.14 Million | $1.13 Billion | $812.85 Million | $147.71 Million | ▲ +7.9 pp |
| 2024 | 50.9% | $526.80 Million | $1.03 Billion | $714.27 Million | $187.47 Million | ▼ -23.5 pp |
| 2023 | 74.4% | $344.97 Million | $463.44 Million | $438.14 Million | $93.17 Million | ▼ -22.2 pp |
| 2022 | 96.7% | $469.55 Million | $485.81 Million | $569.81 Million | $100.27 Million | ▲ +6.8 pp |
| 2021 | 89.9% | $488.06 Million | $542.94 Million | $534.72 Million | $46.66 Million | ▲ +207.9 pp |
| 2020 | -118.0% | $243.34 Million | $-206.29 Million | $266.44 Million | $23.10 Million | ▼ -61.9 pp |
| 2019 | -56.1% | $69.71 Million | $-124.27 Million | $76.40 Million | $6.68 Million | — |